Cochlear Limited Stock Today
| CHEOF Stock | USD 169.07 0.51 0.30% |
PerformanceWeakest
| Odds Of DistressLow
|
Cochlear is trading at 169.07 as of the 6th of January 2026. This is a 0.30 percent increase since the beginning of the trading day. The stock's lowest day price was 169.07. Cochlear has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 7th of December 2025 and ending today, the 6th of January 2026. Click here to learn more.
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company was founded in 1981 and is headquartered in Sydney, Australia. Cochlear Ord operates under Medical Devices classification in the United States and is traded on OTC Exchange. The company has 65.78 M outstanding shares. More on Cochlear Limited
Moving against Cochlear Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Cochlear Pink Sheet Highlights
| President - Services | Stuart Sayers |
| Business Concentration | Medical Devices, Healthcare (View all Sectors) |
Cochlear Limited [CHEOF] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Mid-Cap' category with a current market capitalization of 9.77 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cochlear's market, we take the total number of its shares issued and multiply it by Cochlear's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Cochlear Limited classifies itself under Healthcare sector and is part of Medical Devices industry. The entity has 65.78 M outstanding shares.
Cochlear Limited has accumulated about 629.3 M in cash with 376.5 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.57.
Check Cochlear Probability Of Bankruptcy
Ownership AllocationCochlear holds a total of 65.78 Million outstanding shares. 30% of Cochlear Limited outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Cochlear Ownership Details
Cochlear Limited Risk Profiles
| Mean Deviation | 1.09 | |||
| Standard Deviation | 2.5 | |||
| Variance | 6.27 | |||
| Risk Adjusted Performance | (0.01) |
Cochlear Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Cochlear without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Competition Analyzer Now
Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities |
| All Next | Launch Module |
Cochlear Corporate Management
| David Hackshall | Chief Officer | Profile | |
| MBA BE | MD, CEO | Profile | |
| Richard MBA | Pres EMEA | Profile | |
| Jennifer Stevenson | VP Brand | Profile |
Other Information on Investing in Cochlear Pink Sheet
Cochlear financial ratios help investors to determine whether Cochlear Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cochlear with respect to the benefits of owning Cochlear security.